The nation of Zimbabwe has declined a major US health deal worth 367 million US dollars (£272m) over five years because of Washington's insistence on sensitive information.
This rejection became public after a internal memorandum dated December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the deal was "unbalanced".
An official spokesperson later stated that the US was requesting genetic material for scientific study and profit while refused to guarantee the resulting advantages from future vaccines.
"We must now begin the difficult and regrettable task of ending our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had provided more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has urged continued talks to reach a agreement agreeable to all parties so the country's vital HIV treatment initiative can proceed.
Broader Context
This rejection follows a similar case in neighbouring Kenya, where a high court suspended a related deal with the US following concerns were raised about the safety of Kenyans' health data.
After resuming office last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered aid for the US government, but Trump stated its expenditure was "inefficient" and his administration was pursuing government-to-government agreements to enhance transparency and accountability.
According to statements, 16 nations in Africa have to date signed similar health pacts, constituting over $18.3bn of fresh investment.
Specifics of the Rejected Agreement
This assistance for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We believe this partnership could have provided significant advantages for the people of Zimbabwe, especially the 1.2 million currently on HIV treatment through US-supported initiatives," Tremont added.
However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to share its genetic material and health information over an extended period, with no corresponding promise of access to any scientific breakthroughs – such as new medicines or tests – that could result from that shared data," his statement read.
"Put simply, our nation would provide the basic resources for scientific discovery with no assurance that the final treatments would be available to our population if a new disease outbreak arise."
National Interest and Global Health
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were upending frameworks previously set up through the global health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to deal with potential pandemics.
"This mechanism is designed to guarantee that when a country provides its data, the benefits – such as medicines and cures – are distributed fairly, not commercialised solely by those with the resources to create them."
The government's concerns regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We are open to ongoing dialogue with our US partners on how future co-operation might be designed in a way that respects the sovereignty and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the government's concerns, but urged that talks must proceed since a large portion of the country's Aids initiatives relied on external financing.
"If technical issues exist, including those relating to data governance or agreement terms, these can frequently be resolved through technical clarification and negotiated safeguards," the group commented.
This impasse emphasises the complex tensions between receiving vital international aid and protecting local interests in an increasingly interconnected world.